Pooled Data Back Short-Course HCV Tx
(MedPage Today) -- A short-course treatment of glecaprevir-pibrentasvir (Mavyret) was efficacious and well tolerated in treatment-naive patients with all hepatitis C virus (HCV) genotype infections with or without cirrhosis, international researchers...
Read more »